Mitral valve repair co attracts J&J:
This article was originally published in Clinica
Cardiac Dimensions (CDI), a Kirkland, Washington company specialising in percutaneous functional mitral valve repair, has closed a $35.5m series D financing round co-led by J&J and Lumira Capital. Other investors include Mitsubishi UFJ Capital, West River Capital, Montgomery and CDI's existing shareholders. The funds will enable CDI to begin US and European clinical trials of its Carillon mitral contour system, used for the percutaneous treatment of functional mitral regurgitation. According to CDI, the majority of the 20 million people worldwide who suffer from heart failure also suffer from dilated cardiomyopathy and FMR.
You may also be interested in...
Private Company Edition: Venture capital financings didn’t take a break during Thanksgiving week. In addition to the $800m Resilience raised to fund manufacturing services, SomaLogic closed a $121m series A round to fund its proteomic tools for drug discovery and diagnostics development.
The $250m deal adds A&E Medical’s sternal sutures, cable systems, and rigid fixation systems to Zimmer Biomet’s Dental, Spine & Craniomaxillofacial and Thoracic business.
The Phase III clinical trial showed a noticeable placebo effect compared with OV101.